CN103497154A - Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells - Google Patents
Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells Download PDFInfo
- Publication number
- CN103497154A CN103497154A CN201310349220.0A CN201310349220A CN103497154A CN 103497154 A CN103497154 A CN 103497154A CN 201310349220 A CN201310349220 A CN 201310349220A CN 103497154 A CN103497154 A CN 103497154A
- Authority
- CN
- China
- Prior art keywords
- water
- perylene
- soluble
- compounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 title claims abstract description 82
- -1 perylene imide compounds Chemical class 0.000 title claims abstract description 70
- 239000012625 DNA intercalator Substances 0.000 title claims description 6
- 206010028980 Neoplasm Diseases 0.000 title description 3
- 201000011510 cancer Diseases 0.000 title description 3
- 230000009036 growth inhibition Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 125000003277 amino group Chemical group 0.000 claims abstract description 23
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000005907 cancer growth Effects 0.000 claims abstract description 10
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 17
- 239000012265 solid product Substances 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 13
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 229920000768 polyamine Polymers 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000011259 mixed solution Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 238000010189 synthetic method Methods 0.000 claims description 9
- 150000003512 tertiary amines Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000002390 rotary evaporation Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 150000003866 tertiary ammonium salts Chemical class 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000008098 formaldehyde solution Substances 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 6
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 6
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 13
- 238000000799 fluorescence microscopy Methods 0.000 abstract description 11
- 210000004940 nucleus Anatomy 0.000 abstract description 10
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 230000002112 DNA intercalation Effects 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 210000003855 cell nucleus Anatomy 0.000 abstract description 3
- 239000000138 intercalating agent Substances 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000000975 dye Substances 0.000 description 6
- 210000003079 salivary gland Anatomy 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 5
- 238000002983 circular dichroism Methods 0.000 description 4
- 238000001142 circular dichroism spectrum Methods 0.000 description 4
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 0 Cc1ccc(*)cc1 Chemical compound Cc1ccc(*)cc1 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000001418 larval effect Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- MALZYBOXBVXCSN-UHFFFAOYSA-N 11h-pyrido[3,2-a]carbazole Chemical class C1=CC2=NC=CC=C2C2=C1C1=CC=CC=C1N2 MALZYBOXBVXCSN-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical group CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- SPGFRJWXHIGEOF-UHFFFAOYSA-N CC(C)N(C)[I](C)[N](C(c1ccc(-c2ccc3CN4)c5c1c1ccc5-c(cc5)c2c3c5C4=O)=O)(C1=O)OS Chemical compound CC(C)N(C)[I](C)[N](C(c1ccc(-c2ccc3CN4)c5c1c1ccc5-c(cc5)c2c3c5C4=O)=O)(C1=O)OS SPGFRJWXHIGEOF-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 238000006824 Eschweiler-Clarke methylation reaction Methods 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- OTLWCJRJIBPXDA-UHFFFAOYSA-N O=C(C(C=CC(C12)c3ccc4)=C1C1=CC=C2c2c3c4ccc2)NC1=O Chemical compound O=C(C(C=CC(C12)c3ccc4)=C1C1=CC=C2c2c3c4ccc2)NC1=O OTLWCJRJIBPXDA-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 239000000990 laser dye Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
本发明公开了属于生物药物化学合成技术领域的一种水溶性苝酰亚胺类化合物及其作为DNA嵌插剂和在抑制癌细胞生长中的应用。本发明将阳离子型的胺基官能团引入到苝酐类衍生物及苝单酐体系内,极大的提高了其水溶性,并且与苝类衍生物的光稳定性结合,得到了一系列新型水溶性苝酰亚胺类化合物。本发明合成的水溶性苝酰亚胺类化合物能够有效的嵌入到细胞核DNA双螺旋碱基对之间,可以作为DNA嵌插剂。本发明合成的水溶性苝酰亚胺类化合物具有平面刚性结构,能够特异性的富集在固定组织细胞核,荧光强、易于荧光成像、可与商业化的细胞核染料DAPI效果媲美。本发明合成的水溶性苝酰亚胺类化合物可有效抑制U2OS、HCT116、Hela和AGS等癌细胞生长,具有明显的抗肿瘤效果。
The invention discloses a water-soluble perylene imide compound and its application as a DNA intercalating agent and in inhibiting the growth of cancer cells, which belong to the technical field of chemical synthesis of biological medicines. The present invention introduces cationic amine functional groups into perylene anhydride derivatives and perylene monoanhydride systems, greatly improving their water solubility, and combining with the light stability of perylene derivatives, a series of new water-soluble Sexual perylene imide compounds. The water-soluble perylene imide compound synthesized by the invention can effectively intercalate between the double-helix base pairs of cell nucleus DNA, and can be used as a DNA intercalation agent. The water-soluble peryleneimide compound synthesized by the invention has a planar rigid structure, can be specifically enriched in fixed tissue nuclei, has strong fluorescence, is easy to perform fluorescence imaging, and is comparable in effect to the commercial nuclear dye DAPI. The water-soluble peryleneimide compound synthesized by the invention can effectively inhibit the growth of cancer cells such as U2OS, HCT116, Hela and AGS, and has obvious antitumor effect.
Description
技术领域technical field
本发明属于生物药物化学合成技术领域,特别涉及一种水溶性苝酰亚胺类化合物及其作为DNA嵌插剂和在抑制癌细胞生长中的应用。The invention belongs to the technical field of biopharmaceutical chemical synthesis, and particularly relates to a water-soluble perylene imide compound and its application as a DNA intercalation agent and in inhibiting the growth of cancer cells.
背景技术Background technique
苝及其衍生物具有很好的光、热、化学稳定性,几乎100%的荧光量子产率,窄的荧光发射峰,能够与细胞背景荧光(395-479nm)分开以及优异的染色性能,目前已广泛应用于有机光电器件、激光染料以及生物荧光探针领域。Perylene and its derivatives have good light, thermal and chemical stability, almost 100% fluorescence quantum yield, narrow fluorescence emission peak, can be separated from cell background fluorescence (395-479nm) and excellent dyeing performance. It has been widely used in the fields of organic optoelectronic devices, laser dyes and bioluminescent probes.
嵌插剂(intercalator)是指多环芳烃小分子物质与DNA的可逆性相互作用。这类分子体积小,处于缺电子状态,并具有一定的平面刚性,可以插入到DNA两个堆积的碱基对之间,嵌入过程导致DNA的螺旋延伸和解链。目前研究较多的DNA嵌插剂有吖啶类、吡啶并咔唑类、苯并咪唑[1,2-C]喹啉类、蒽醌类等,并且都被用作抗肿瘤研究。然而具有良好平面刚性结构的苝类衍生物还没有被作为DNA嵌插剂来研究其抗肿瘤性能。Intercalator refers to the reversible interaction between polycyclic aromatic hydrocarbon small molecule substances and DNA. This type of molecule is small in size, in an electron-deficient state, and has a certain planar rigidity. It can be inserted between two stacked base pairs of DNA. The insertion process leads to the helical extension and unzipping of DNA. At present, DNA intercalation agents that have been studied more include acridines, pyridocarbazoles, benzimidazol[1,2-C]quinolines, anthraquinones, etc., and all of them have been used in antitumor research. However, perylene derivatives with good planar rigid structures have not been used as DNA intercalators to study their antitumor properties.
近年来,苝酰亚胺类化合物已经应用于生物领域,如细胞特异性标记,然而较差的水溶性直接影响了它在这一领域的应用,因此提高此类化合物的水溶性及在水溶液中保持高荧光量子产率对其在生物领域,尤其是DNA嵌插剂领域具有重要意义。In recent years, perylene imide compounds have been used in the biological field, such as cell-specific labeling, but poor water solubility directly affects its application in this field, so the water solubility of these compounds and the Maintaining a high fluorescence quantum yield is of great significance in the field of biology, especially in the field of DNA intercalators.
发明内容Contents of the invention
本发明的目的在于提供一类光、热、化学稳定性好、水溶性好、结构具有可设计性的苝酰亚胺类化合物,并将其应用于生物医学领域,具体研究了作为DNA嵌插剂和在抑制癌细胞生长中的应用。The object of the present invention is to provide a class of peryleneimide compounds with good light, heat and chemical stability, good water solubility and designable structure, and apply it to the field of biomedicine. agents and their use in inhibiting the growth of cancer cells.
本发明的技术方案为:首先选择苝酐或苝单酐作为荧光发射团,然后与含有胺基官能团的化合物反应,制备具有胺基官能团修饰的苝酰亚胺衍生物及苝单酰亚胺衍生物;然后通过Eschweiler–Clarke反应制备具有叔胺官能团修饰的苝酰亚胺衍生物及苝单酰亚胺衍生物;最终反应得到含有叔胺盐或季铵盐等不同阳离子化的苝酰亚胺衍生物及苝单酰亚胺衍生物。通过紫外吸收光谱、荧光发射光谱、圆二色谱(CD)分析这些苝酰亚胺衍生物与DNA相互作用,确认这些化合物具有优异的DNA嵌插性能,同时可以作为DNA嵌插剂来抑制肿瘤细胞的生长。然后,通过细胞和组织水平的研究与表征,证明本发明合成的苝酰亚胺衍生物具有细胞核的特异性富集作用和抑制癌细胞生长方面的作用。The technical scheme of the present invention is: first select perylene anhydride or perylene monoimide as the fluorescent emitting group, and then react with a compound containing an amino functional group to prepare perylene imide derivatives and perylene monoimide derivatives modified with amino functional groups. Then, the peryleneimide derivatives and perylene monoimide derivatives with tertiary amine functional group modification are prepared by Eschweiler–Clarke reaction; the final reaction is to obtain different cationized peryleneimides containing tertiary amine salts or quaternary ammonium salts. Derivatives and perylene monoimide derivatives. The interaction between these peryleneimide derivatives and DNA was analyzed by ultraviolet absorption spectroscopy, fluorescence emission spectroscopy, and circular dichroism (CD), confirming that these compounds have excellent DNA intercalation properties, and can be used as DNA intercalation agents to inhibit tumor cells growth. Then, through cell and tissue level research and characterization, it is proved that the perylene imide derivative synthesized by the present invention has the specific enrichment effect of the nucleus and the effect of inhibiting the growth of cancer cells.
本发明所述的水溶性苝酰亚胺类化合物是含苝酰亚胺或苝单酰亚胺结构的多胺衍生物,其结构通式为:The water-soluble peryleneimide compound of the present invention is a polyamine derivative containing peryleneimide or perylene monoimide structure, and its general structural formula is:
或or
或or
或or
其中,R2=CH3或CH2CH3,R3=H或CH3或CH2CH3。in, R 2 =CH 3 or CH 2 CH 3 , R 3 =H or CH 3 or CH 2 CH 3 .
本发明所述的水溶性苝酰亚胺类化合物的合成方法,其具体制备步骤为:The synthetic method of water-soluble perylene imide compound of the present invention, its specific preparation steps are:
(1)将2mmol的苝酐和6-12mmol的胺类化合物加入3-6mL水中搅拌均匀,然后升温至100-120℃,回流反应12-24h,降到室温后,用1-2wt%KOH水溶液和水洗涤,干燥得到产物;(1) Add 2mmol of perylene anhydride and 6-12mmol of amine compound into 3-6mL of water and stir evenly, then raise the temperature to 100-120°C, reflux for 12-24h, after cooling down to room temperature, use 1-2wt% KOH aqueous solution Wash with water and dry to obtain the product;
(2)将0.6mmol步骤(1)得到的产物与5-9mmol的对甲基苯磺酸在3-6mL水中于50-60℃反应4-8h后过滤,滤液经旋转蒸发除去溶剂,接着用丙酮分散,用乙醚沉淀洗涤,离心、干燥,得到叔铵盐苝酰亚胺类化合物;(2) React 0.6mmol of the product obtained in step (1) with 5-9mmol of p-toluenesulfonic acid in 3-6mL of water at 50-60°C for 4-8h and then filter. Disperse with acetone, precipitate and wash with ether, centrifuge and dry to obtain tertiary ammonium salt perylene imide compounds;
或者将0.6mmol步骤(1)得到的产物与5-9mmol的对甲基苯磺酸甲酯在50-60℃反应18-24h后,加3-5mL甲醇到反应混合溶液中过滤,通过旋转蒸发对滤液进行浓缩,然后用乙醚进行沉淀洗涤,离心、干燥后得到季铵盐苝酰亚胺类化合物;Or react 0.6mmol of the product obtained in step (1) with 5-9mmol of methyl p-toluenesulfonate at 50-60°C for 18-24h, add 3-5mL of methanol to the reaction mixture solution and filter it, and use rotary evaporation The filtrate is concentrated, then precipitated and washed with ether, centrifuged and dried to obtain quaternary ammonium perylene imide compounds;
步骤(1)所述的胺类化合物为含有一个端胺基的叔胺类化合物,其分子式通式为NH2(R1NH)0-5R1N(R2)2,其中R1为含有2-6个亚甲基的烷基链,R2为甲基或乙基;The amine compound described in step (1) is a tertiary amine compound containing one terminal amino group, and its molecular formula is NH 2 (R 1 NH) 0-5 R 1 N(R 2 ) 2 , wherein R 1 is An alkyl chain containing 2-6 methylene groups, R 2 is methyl or ethyl;
上述制得的叔铵盐苝酰亚胺类化合物和季铵盐苝酰亚胺类化合物为含2-12个胺基功能化的水溶性线性苝酰亚胺类化合物。The tertiary ammonium salt perylene imide compound and the quaternary ammonium salt perylene imide compound prepared above are water-soluble linear perylene imide compounds containing 2-12 functionalized amine groups.
步骤(1)所述的胺类化合物优选N,N-二甲基乙二胺或N,N-二乙基二乙烯基三胺。The amine compound described in step (1) is preferably N,N-dimethylethylenediamine or N,N-diethyldivinyltriamine.
本发明所述的水溶性苝酰亚胺类化合物的合成方法,其具体制备步骤为:The synthetic method of water-soluble perylene imide compound of the present invention, its specific preparation steps are:
1)将苝酐和多胺类化合物按摩尔比为(1:40)-(1:60)加入回流反应瓶中,氮气气氛下加热到98-110℃反应24-28h,然后升温到170-180℃继续反应2-5h,降到室温后,加入体积比为(1:2)-(1:4)的乙醇与乙醚的混合溶剂,过滤,然后用甲苯、乙醚洗涤固体产物,干燥;1) Add perylene anhydride and polyamines in a molar ratio of (1:40)-(1:60) into a reflux reaction flask, heat to 98-110°C for 24-28h under a nitrogen atmosphere, and then heat up to 170- Continue to react at 180°C for 2-5 hours, after cooling down to room temperature, add a mixed solvent of ethanol and ether with a volume ratio of (1:2)-(1:4), filter, then wash the solid product with toluene and ether, and dry;
2)将138mg步骤1)得到的产物加入到1-2mL的混合溶液中,所述的混合溶液为80-86wt%的甲酸溶液和25-35wt%的甲醛溶液按体积比(1.2:1)-(1.5:1)配制得到,氮气气氛下搅拌0.5-1.5小时后加热到90-120℃反应12-18小时,降到室温后,用乙醚沉淀洗涤,干燥得到叔胺官能化的苝酰亚胺类化合物;2) Add 138mg of the product obtained in step 1) to 1-2mL of the mixed solution, the mixed solution is 80-86wt% formic acid solution and 25-35wt% formaldehyde solution in volume ratio (1.2:1)- (1.5:1) prepared, stirred under nitrogen atmosphere for 0.5-1.5 hours, then heated to 90-120 ° C for 12-18 hours, after cooling down to room temperature, washed with ether precipitation, dried to obtain tertiary amine functionalized peryleneimide Compounds;
3)将100mg步骤2)得到的叔胺官能化的苝酰亚胺类化合物溶于2-4mL的甲醇或乙腈溶剂中,然后滴加0.2-0.4mL碘甲烷或0.2-0.5mL碘乙烷,在氮气气氛下加热到60-80℃,得到季铵盐苝酰亚胺类化合物;3) Dissolve 100 mg of the tertiary amine-functionalized perylene imide compound obtained in step 2) in 2-4 mL of methanol or acetonitrile solvent, then add 0.2-0.4 mL of iodomethane or 0.2-0.5 mL of iodoethane dropwise, Heating to 60-80°C under a nitrogen atmosphere to obtain quaternary ammonium peryleneimide compounds;
步骤1)所述的多胺类化合物为含有三个端胺基的胺类化合物,其分子式通式为NH2(R1NH)0-5R1N(R1NH2)2,其中R1为含有2-6个亚甲基的烷基链;The polyamine compound in step 1) is an amine compound containing three terminal amino groups, and its molecular formula is NH 2 (R 1 NH) 0-5 R 1 N(R 1 NH 2 ) 2 , where R 1 is an alkyl chain containing 2-6 methylene groups;
上述制得的叔胺官能化的苝酰亚胺类化合物和季铵盐苝酰亚胺类化合物为含6-16个胺基功能化的水溶性支化苝酰亚胺类化合物。The above prepared tertiary amine functionalized peryleneimide compounds and quaternary ammonium salt peryleneimide compounds are water-soluble branched peryleneimide compounds containing 6-16 functionalized amine groups.
步骤1)所述的多胺类化合物优选三(2-氨基乙基)胺。The polyamine compound described in step 1) is preferably tris(2-aminoethyl)amine.
本发明所述的水溶性苝酰亚胺类化合物的合成方法,其具体制备步骤为:The synthetic method of water-soluble perylene imide compound of the present invention, its specific preparation steps are:
(1)将2mmol的苝单酐和5-10mmol的胺类化合物加入3-6mL水中搅拌均匀,然后升温至100-120℃,回流反应12-24h,降到室温后,用1-2wt%KOH水溶液和水洗涤,干燥得到产物;(1) Add 2mmol of perylene monoanhydride and 5-10mmol of amine compounds into 3-6mL of water and stir evenly, then heat up to 100-120°C, reflux for 12-24h, after cooling down to room temperature, use 1-2wt% KOH Washing with aqueous solution and water, and drying to obtain the product;
(2)将0.5mmol步骤(1)得到的产物与2.5-5mmol的对甲基苯磺酸在2-4mL水中于50-60℃反应4-8h后过滤,滤液经旋转蒸发除去溶剂,用乙醚沉淀洗涤,离心、干燥,得到叔铵盐苝单酰亚胺类化合物;(2) React 0.5mmol of the product obtained in step (1) with 2.5-5mmol of p-toluenesulfonic acid in 2-4mL of water at 50-60°C for 4-8h, then filter, remove the solvent by rotary evaporation, and diethyl ether precipitation washing, centrifugation and drying to obtain tertiary ammonium salt perylene monoimide compounds;
或者将0.5mmol步骤(1)得到的产物与2.5-5mmol的对甲基苯磺酸甲酯在50-60℃反应18-24h后过滤,通过旋转蒸发对滤液进行浓缩,然后用乙醚进行沉淀洗涤,离心、干燥后得到季铵盐苝单酰亚胺类化合物;Or react 0.5mmol of the product obtained in step (1) with 2.5-5mmol of methyl p-toluenesulfonate at 50-60°C for 18-24h, then filter, concentrate the filtrate by rotary evaporation, and then wash with ether for precipitation , centrifuged and dried to obtain quaternary ammonium perylene monoimide compounds;
步骤(1)所述的胺类化合物为含有一个端胺基的叔胺类化合物,其分子式通式为NH2(R1NH)0-5R1N(R2)2,其中R1为含有2-6个亚甲基的烷基链,R2为甲基或乙基;The amine compound described in step (1) is a tertiary amine compound containing one terminal amino group, and its molecular formula is NH 2 (R 1 NH) 0-5 R 1 N(R 2 ) 2 , wherein R 1 is An alkyl chain containing 2-6 methylene groups, R 2 is methyl or ethyl;
上述制得的叔铵盐苝单酰亚胺类化合物和季铵盐苝单酰亚胺类化合物为含1-6个胺基功能化的水溶性线性苝酰亚胺类化合物。The tertiary ammonium salt perylene monoimide compound and the quaternary ammonium salt perylene monoimide compound prepared above are water-soluble linear perylene imide compounds containing 1-6 functionalized amine groups.
步骤(1)所述的胺类化合物优选N,N-二甲基乙二胺或N,N-二乙基二乙烯基三胺。The amine compound described in step (1) is preferably N,N-dimethylethylenediamine or N,N-diethyldivinyltriamine.
本发明所述的水溶性苝酰亚胺类化合物的合成方法,其具体制备步骤为:The synthetic method of water-soluble perylene imide compound of the present invention, its specific preparation steps are:
1)将苝单酐和多胺类化合物按摩尔比为(1:40)-(1:60)加入回流反应瓶中,氮气气氛下加热到98-110℃反应24-28h,然后升温到170-180℃继续反应2-5h,降到室温后,加入体积比为(1:2)-(1:4)的乙醇与乙醚的混合溶剂,过滤,然后用甲苯、乙醚洗涤固体产物,干燥;1) Add perylene monoanhydride and polyamines in a molar ratio of (1:40)-(1:60) into the reflux reaction flask, heat to 98-110°C for 24-28h under nitrogen atmosphere, and then raise the temperature to 170°C Continue the reaction at -180°C for 2-5 hours, after cooling down to room temperature, add a mixed solvent of ethanol and ether with a volume ratio of (1:2)-(1:4), filter, then wash the solid product with toluene and ether, and dry;
2)将150mg步骤1)得到的产物加入到1.0-2mL的混合溶液中,所述的混合溶液为80-86wt%的甲酸溶液和25-35wt%的甲醛溶液按体积比(1.2:1)-(1.5:1)配制得到,氮气气氛下搅拌0.5-1.5小时后加热到90-120℃反应12-18小时,降到室温后,用乙醚沉淀洗涤,干燥得到叔胺官能化的苝单酰亚胺类化合物;2) Add 150mg of the product obtained in step 1) to 1.0-2mL of the mixed solution, the mixed solution is 80-86wt% formic acid solution and 25-35wt% formaldehyde solution in volume ratio (1.2:1)- (1.5:1) prepared, stirred under nitrogen atmosphere for 0.5-1.5 hours, then heated to 90-120 ° C for 12-18 hours, after cooling down to room temperature, washed with ether precipitation, dried to obtain tertiary amine functionalized perylene monoimide Amine compounds;
3)将100mg步骤2)得到的叔胺官能化的苝单酰亚胺类化合物溶于2-4mL甲醇或乙腈溶剂中,然后滴加0.2-0.4mL碘甲烷或0.2-0.5mL碘乙烷,在氮气气氛下加热到60-80℃,得到季铵盐苝单酰亚胺类化合物;3) Dissolve 100 mg of the tertiary amine-functionalized perylene monoimide compound obtained in step 2) in 2-4 mL of methanol or acetonitrile solvent, then add 0.2-0.4 mL of iodomethane or 0.2-0.5 mL of iodoethane dropwise, Heating to 60-80°C under a nitrogen atmosphere to obtain quaternary ammonium salt perylene monoimide compounds;
步骤1)所述的多胺类化合物为含有三个端胺基的胺类化合物,其分子式通式为NH2(R1NH)0-5R1N(R1NH2)2,其中R1为含有2-6个亚甲基的烷基链;The polyamine compound in step 1) is an amine compound containing three terminal amino groups, and its molecular formula is NH 2 (R 1 NH) 0-5 R 1 N(R 1 NH 2 ) 2 , where R 1 is an alkyl chain containing 2-6 methylene groups;
上述制得的叔胺官能化的苝单酰亚胺类化合物和季铵盐苝单酰亚胺类化合物为含3-8个胺基功能化的水溶性支化苝酰亚胺类化合物。The above prepared tertiary amine functionalized perylene monoimide compounds and quaternary ammonium salt perylene monoimide compounds are water-soluble branched perylene imide compounds containing 3-8 functionalized amine groups.
步骤1)所述的多胺类化合物优选三(2-氨基乙基)胺。The polyamine compound described in step 1) is preferably tris(2-aminoethyl)amine.
将上述水溶性苝酰亚胺类化合物作为DNA嵌插剂的应用。The application of the above-mentioned water-soluble peryleneimide compound as a DNA intercalation agent.
将上述水溶性苝酰亚胺类化合物作为细胞核染料的应用。The application of the above-mentioned water-soluble peryleneimide compound as a cell nucleus dye.
将上述水溶性苝酰亚胺类化合物作为抑制癌细胞生长药物的应用。The application of the above-mentioned water-soluble perylene imide compound as a drug for inhibiting the growth of cancer cells.
本发明具有如下有益效果:The present invention has following beneficial effects:
1.以苝酐类衍生物及其类似物作为荧光发射团,通过不同的合成方法合成了一系列带有不同胺基功能基团的水溶性苝酰亚胺类化合物;该类化合物具有良好的光、热、化学稳定性、荧光量子产率高、水溶性好、结构可设计性等特性。1. Using perylene anhydride derivatives and their analogs as fluorescent emission groups, a series of water-soluble peryleneimide compounds with different amine functional groups were synthesized through different synthetic methods; these compounds have good Light, heat, chemical stability, high fluorescence quantum yield, good water solubility, and structural designability.
2.本发明合成的水溶性苝酰亚胺类化合物能够有效的嵌入到细胞核DNA双螺旋碱基对之间,可以作为DNA嵌插剂,具有很好的实际应用价值。2. The water-soluble peryleneimide compound synthesized by the present invention can effectively intercalate between the base pairs of the DNA double helix in the cell nucleus, and can be used as a DNA intercalation agent, which has good practical application value.
3.本发明合成的水溶性苝酰亚胺类化合物具有平面刚性结构,能够特异性的富集在固定组织细胞核,荧光强、易于荧光成像、可与商业化的细胞核染料DAPI效果媲美。3. The water-soluble peryleneimide compound synthesized by the present invention has a planar rigid structure, can be specifically enriched in fixed tissue nuclei, has strong fluorescence, is easy to perform fluorescence imaging, and is comparable to the effect of the commercial nuclear dye DAPI.
4.本发明合成的水溶性苝酰亚胺类化合物可有效抑制U2OS、HCT116、Hela和AGS等癌细胞生长,具有明显的抗肿瘤效果;使其在生物医药的科研、诊断、治疗领域具有广阔的应用前景。4. The water-soluble peryleneimide compound synthesized by the present invention can effectively inhibit the growth of cancer cells such as U2OS, HCT116, Hela and AGS, and has obvious anti-tumor effect; it has broad application in the fields of scientific research, diagnosis and treatment of biomedicine application prospects.
5.本发明合成方法简单,容易大量合成,具有很好的应用价值。5. The synthesis method of the present invention is simple, easy to synthesize in large quantities, and has good application value.
附图说明Description of drawings
图1水溶性苝酰亚胺类化合物P2嵌插到DNA碱基对间的分子模型图,以及应用于特异性细胞核富集的荧光成像图和抑制HCT116细胞生长的柱状图。Figure 1: Molecular model diagram of intercalation of water-soluble peryleneimide compound P2 into DNA base pairs, as well as fluorescence imaging diagram applied to specific nucleus enrichment and histogram of inhibition of HCT116 cell growth.
图2实施例1和实施例2中合成水溶性苝酰亚胺类化合物的反应流程图。The reaction flow chart of synthesizing water-soluble perylene imide compounds in Fig. 2 embodiment 1 and embodiment 2.
图3实施例3和实施例4中合成水溶性苝单酰亚胺类化合物的反应流程图。The reaction flow chart of synthesizing water-soluble perylene monoimide compounds in Fig. 3 embodiment 3 and embodiment 4.
图4水溶性苝酰亚胺类化合物P2,P3,P5和P6(5.0μM)在磷酸缓冲液(10mM,pH7.4)中与Ct-DNA作用的(A1-A4)紫外吸收和(B1-B4)荧光发射光谱图。Figure 4 (A1-A4) UV absorption and (B1- B4) Fluorescence emission spectrum diagram.
图5固定Ct-DNA浓度为80μM,在磷酸缓冲液(10mM,pH7.4)中,添加水溶性苝酰亚胺类化合物P2,P3,P5和P6(3μM)以及空白试验的(A-D)CD光谱图。Figure 5 The fixed Ct-DNA concentration is 80μM, in phosphate buffer (10mM, pH7.4), adding water-soluble peryleneimide compounds P2, P3, P5 and P6 (3μM) and blank test (A-D) CD Spectrum.
图6果蝇唾液腺固定组织在水溶性苝酰亚胺类化合物P2,P3与DAPI共染色下的荧光成像。(A-B)10μΜ的P2,P3(亚酰胺部位连接两个胺基取代基,P2,P3具有刚性平面框架结构)分别染色标记果蝇唾液腺,546nm光道荧光成像,特异性的富集在细胞核上。(A’-B’)细胞核染料DAPI染色标记果蝇幼虫唾液腺组织,405nm光道下荧光成像图。(A”-B”)P2,P3细胞核荧光定位成像效果与DAPI荧光成像效果完全重合。Fig. 6 Fluorescence imaging of Drosophila salivary gland fixed tissue under the co-staining of water-soluble peryleneimide compounds P2, P3 and DAPI. (A-B) 10 μM of P2, P3 (two amine substituents connected to the imide site, P2, P3 have a rigid planar framework structure) were stained to mark Drosophila salivary glands, 546nm channel fluorescence imaging, specifically enriched in the nucleus . (A'-B') Drosophila larval salivary gland tissue stained with nuclear dye DAPI, fluorescence imaging under 405nm light channel. (A"-B") P2, P3 nuclei fluorescence localization imaging effect completely coincides with DAPI fluorescence imaging effect.
图7果蝇唾液腺固定组织在水溶性苝酰亚胺类化合物P5,P6与DAPI共染色下的荧光成像。(A-B)10μΜ的P5,P6(亚酰胺部位连接四个胺基取代基,P5,P6具有刚性平面框架结构)分别染色标记果蝇唾液腺,546nm光道荧光成像,特异性的富集在细胞核上。(A’-B’)细胞核染料DAPI染色标记果蝇幼虫唾液腺组织,405nm光道下荧光成像图。(A”-B”)P5,P6细胞核荧光定位成像效果与DAPI荧光成像效果完全重合。Fig. 7 Fluorescence imaging of Drosophila salivary gland fixed tissue under the co-staining of water-soluble peryleneimide compounds P5, P6 and DAPI. (A-B) 10 μM of P5, P6 (the imide site is connected with four amine substituents, P5, P6 have a rigid planar frame structure) were stained to mark the salivary glands of Drosophila, and the 546nm channel fluorescence imaging was specifically enriched on the nucleus . (A'-B') Drosophila larval salivary gland tissue stained with nuclear dye DAPI, fluorescence imaging under 405nm light channel. (A"-B") P5, P6 nuclei fluorescence localization imaging effect completely coincides with DAPI fluorescence imaging effect.
具体实施方式Detailed ways
下面结合具体的实施例,对本发明做进一步阐述。本发明不限于这些具体的实施例。The present invention will be further elaborated below in conjunction with specific embodiments. The present invention is not limited to these specific examples.
产物结构的表征使用:核磁1H和13C谱(Bruker400),质谱AXIMA-CFRplusMALDI-TOFMS。The characterization of the product structure used: nuclear magnetic 1 H and 13 C spectrum (Bruker400), mass spectrometry AXIMA-CFRplusMALDI-TOFMS.
产物光学性能表征使用:紫外可见光谱(Cintra20,GBC,Australia),荧光光谱(HoribaJobinYvonFluoroMax-4NIR,NJ,USA)。The optical properties of the product were characterized using: ultraviolet-visible spectroscopy (Cintra20, GBC, Australia), fluorescence spectroscopy (HoribaJobinYvonFluoroMax-4NIR, NJ, USA).
产物的生物实验表征使用:荧光显微镜(AMGEVOSf1microscope),激光共聚焦显微镜(LeicaTCSSP2AOBSconfocalmicroscope)。The biological experimental characterization of the product uses: fluorescence microscope (AMGEVOSf1microscope), laser confocal microscope (LeicaTCSSP2AOBSconfocalmicroscope).
实施实例1:Implementation example 1:
1)0.7846g苝酐(2.0mmol)和0.34mLN,N-二甲基乙二胺(6.0mmol)悬浮于4mL水中搅拌均匀,然后升温至100℃回流反应12h,等温度降到室温后,用1wt%KOH水溶液和水洗涤,经真空干燥后得到红色固体产物P1,产率为75%;1) Suspend 0.7846g perylene anhydride (2.0mmol) and 0.34mL N,N-dimethylethylenediamine (6.0mmol) in 4mL water and stir evenly, then heat up to 100°C and reflux for 12h. After the temperature drops to room temperature, use Wash with 1wt% KOH aqueous solution and water, obtain red solid product P1 after vacuum drying, yield rate is 75%;
1H-NMR(400MHz,CF3COOD),δppm:8.77(d,J=12.3Hz,8H),4.77(s,4H),3.75(s,4H),3.19(s,12H).13C-NMR(100MHz,CF3COOD),δppm:168.67,138.82,135.64,131.77,128.84,126.85,123.97,60.73,46.42,38.74.MS(MALDI-TOF,m/z):CalcdforC32H28N4O4,532.6;Found,533.6(M+H+). 1 H-NMR (400MHz, CF 3 COOD), δppm: 8.77 (d, J=12.3Hz, 8H), 4.77 (s, 4H), 3.75 (s, 4H), 3.19 (s, 12H). 13 C- NMR (100MHz, CF 3 COOD), δppm: 168.67, 138.82, 135.64, 131.77, 128.84, 126.85, 123.97, 60.73, 46.42, 38.74. MS (MALDI-TOF, m/z): CalcdforC 32 H 28 N 4 O 4 ,532.6;Found,533.6(M+H + ).
2)0.32gP1(0.6mmol)与1.02g对甲基苯磺酸(5.4mmol)在3.5mL去离子水溶液中于50℃反应4h后过滤,滤液经旋转蒸发除去溶剂,接着用丙酮分散,用乙醚沉淀洗涤,离心、干燥后得到红色固体产物P2,产率为85%。2) 0.32g P1 (0.6mmol) and 1.02g p-toluenesulfonic acid (5.4mmol) were reacted in 3.5mL deionized aqueous solution at 50°C for 4h and then filtered. The precipitate was washed, centrifuged and dried to obtain the red solid product P2 with a yield of 85%.
1H-NMR(400MHz,CF3COOD),δppm:8.76(s,8H),7.77(s,<2H),7.37(d,J=7.7Hz,4H),6.95(d,J=7.7Hz,4H),4.81(s,4H),3.83(s,4H),3.27(d,J=2.9Hz,12H),1.96(s,6H).13C-NMR(100MHz,CF3COOD),δppm:168.73,146.03,138.67,138.52,135.51,131.73,131.41,128.60,127.62,126.62,124.13,60.54,46.50,38.66,21.72.UV-Vis(H2O,c=5.0×10-6M):λmax(ε)=498nm(2.45×104M-1cm-1);Emission(H2O,λex=498nm):λmax=545nm. 1 H-NMR(400MHz,CF 3 COOD),δppm:8.76(s,8H),7.77(s,<2H),7.37(d,J=7.7Hz,4H),6.95(d,J=7.7Hz, 4H),4.81(s,4H),3.83(s,4H),3.27(d,J=2.9Hz,12H),1.96(s,6H). 13 C-NMR(100MHz,CF 3 COOD),δppm: 168.73,146.03,138.67,138.52,135.51,131.73,131.41,128.60,127.62,126.62,124.13,60.54,46.50,38.66,21.72.UV-Vis(H 2 O,c=5.0×10 -max6 M): λ (ε)=498nm(2.45×10 4 M -1 cm -1 );Emission(H 2 O,λ ex =498nm):λ max =545nm.
P1(0.32g,0.6mmol)与2.5mL对甲基苯磺酸甲酯(5.4mmol)于50℃反应20h,等温度降到室温后,加3mL甲醇到反应混合溶液中过滤,通过旋转蒸发对滤液进行浓缩,然后用乙醚进行沉淀洗涤,离心、干燥后得到红色固体产物P3,产率为80%。P1 (0.32g, 0.6mmol) was reacted with 2.5mL methyl p-toluenesulfonate (5.4mmol) at 50°C for 20h. After the temperature dropped to room temperature, 3mL methanol was added to the reaction mixture and filtered. The filtrate was concentrated, then precipitated and washed with ether, centrifuged and dried to obtain the red solid product P3 with a yield of 80%.
1H-NMR(400MHz,CF3COOD),δppm:8.99(dt,J=15.1,7.6Hz,8H),7.77(d,J=8.1Hz,4H),7.33(d,J=8.0Hz,4H),4.97(d,J=30.0Hz,4H),3.99(d,J=37.7Hz,4H),3.55(s,12H),3.37(s,6H),2.38(s,6H).UV-Vis(H2O,c=10-5M):λmax=498nm;Emission(H2O,λex=498nm):λmax=545nm。 1 H-NMR(400MHz,CF 3 COOD),δppm:8.99(dt,J=15.1,7.6Hz,8H),7.77(d,J=8.1Hz,4H),7.33(d,J=8.0Hz,4H ),4.97(d,J=30.0Hz,4H),3.99(d,J=37.7Hz,4H),3.55(s,12H),3.37(s,6H),2.38(s,6H).UV-Vis (H 2 O,c=10 -5 M):λ max =498nm; Emission(H 2 O,λ ex =498nm):λ max =545nm.
P2和P3为含2个胺基功能化的水溶性线性苝酰亚胺类化合物。P2 and P3 are water-soluble linear perylene imide compounds containing two functionalized amine groups.
P2结构式为The structural formula of P2 is
P3结构式为The structural formula of P3 is
实施实例2:Implementation example 2:
1)将0.81g苝酐(2.1mmol)和15mL三(2-氨基乙基)胺(100.5mmol)加入回流反应瓶中,其中三(2-氨基乙基)胺也为反应溶剂;溶液在氮气气氛下加热到100℃反应28小时,然后升温到170℃继续反应4小时,等温度降到室温后,加入体积比为1:3的乙醇与乙醚的混合溶剂,过滤,然后用甲苯、乙醚洗涤固体产物,干燥后得到红色固体产物P4,产率为90%。1) Add 0.81g perylene anhydride (2.1mmol) and 15mL tris(2-aminoethyl)amine (100.5mmol) into the reflux reaction flask, in which tris(2-aminoethyl)amine is also the reaction solvent; Heat to 100°C for 28 hours under atmosphere, then raise the temperature to 170°C and continue to react for 4 hours. After the temperature drops to room temperature, add a mixed solvent of ethanol and ether with a volume ratio of 1:3, filter, and then wash with toluene and ether The solid product was dried to obtain the red solid product P4 with a yield of 90%.
1H-NMR(400MHz,CF3COOD),δppm:8.82-8.98(m,8H),4.93(m,4H),4.40(m,4H),4.04-4.21(m,16H).UV-Vis(H2O,c=10-5M):λmax=498nm;Emission(H2O,λex=498nm):λmax=545nm.MS(MALDI-TOF,m/z):calcdforC36H40N8O4:648.75.Found:648.3. 1 H-NMR (400MHz, CF 3 COOD), δppm: 8.82-8.98(m, 8H), 4.93(m, 4H), 4.40(m, 4H), 4.04-4.21(m, 16H).UV-Vis( H 2 O,c=10 -5 M):λ max =498nm;Emission(H 2 O,λ ex =498nm):λ max =545nm.MS(MALDI-TOF,m/z):calcdforC 36 H 40 N 8 O 4 :648.75. Found: 648.3.
2)将138mgP4加入到0.64mL85wt%的甲酸溶液和0.44mL30wt%的甲醛溶液组成的混合溶液中,先在氮气气氛下于室温搅拌反应1小时,然后加热到120℃反应16小时,等温度降到室温后,用乙醚沉淀洗涤3次,干燥后得到红色固体产物P5,产率为88%;UV-Vis(H2O,c=10-5M):λmax=498nm;Emission(H2O,λex=498nm):λmax=545nm.MS(MALDI-TOF,m/z):calcdforC44H56N8O4:760.97.Found:761.63.2) Add 138mg of P4 to a mixed solution consisting of 0.64mL85wt% formic acid solution and 0.44mL30wt% formaldehyde solution, stir and react at room temperature under nitrogen atmosphere for 1 hour, then heat to 120°C for 16 hours, and wait for the temperature to drop to After room temperature, it was precipitated and washed with diethyl ether for 3 times, and the red solid product P5 was obtained after drying with a yield of 88%; UV-Vis (H 2 O, c=10 -5 M): λ max =498nm; Emission (H 2 O ,λ ex =498nm):λ max =545nm.MS(MALDI-TOF,m/z):calcdforC 44 H 56 N 8 O 4 :760.97.Found:761.63.
3)将上述100mgP5溶于3mL甲醇溶剂中,然后滴加0.2mL的碘甲烷,在氮气气氛下加热到60℃,得到季铵盐苝酰亚胺类衍生物P6。1H-NMR(400MHz,CF3COOD),δppm:8.95(d,J=34.1Hz,8H),5.04(s,4H),4.51(s,20H),4.26(s,6H),3.56(s,36H).UV-Vis(H2O,c=10-5M):λmax=498nm;Emission(H2O,λex=498nm):λmax=545nm.3) The above 100mg of P5 was dissolved in 3mL of methanol solvent, then 0.2mL of iodomethane was added dropwise, and heated to 60°C under a nitrogen atmosphere to obtain the quaternary ammonium salt peryleneimide derivative P6. 1 H-NMR (400MHz, CF 3 COOD), δppm: 8.95 (d, J=34.1Hz, 8H), 5.04 (s, 4H), 4.51 (s, 20H), 4.26 (s, 6H), 3.56 (s ,36H).UV-Vis(H 2 O,c=10 -5 M):λ max =498nm;Emission(H 2 O,λ ex =498nm):λ max =545nm.
P5和P6为含6个胺基功能化的水溶性支化苝酰亚胺类化合物。P5 and P6 are water-soluble branched perylene imide compounds containing 6 functionalized amine groups.
P5结构式为The structural formula of P5 is
P6结构式为The structural formula of P6 is
实施实例3:Implementation example 3:
(1)0.644g苝单酐(2.0mmol)和0.34mLN,N-二甲基乙二胺(6.0mmol)加入3mL水中搅拌均匀,然后升温至110℃,回流反应15h,降到室温后,用1wt%KOH水溶液和水洗涤,经真空干燥后得到暗红色固体产物M1,产率为79%;(1) Add 0.644g of perylene monoanhydride (2.0mmol) and 0.34mL of N,N-dimethylethylenediamine (6.0mmol) into 3mL of water and stir evenly, then heat up to 110°C, reflux for 15h, after cooling down to room temperature, use Washed with 1wt% KOH aqueous solution and water, and dried in vacuo to obtain dark red solid product M1 with a yield of 79%;
(2)0.196gM1(0.5mmol)与0.51g对甲基苯磺酸(2.7mmol)在2mL去离子水溶液中于55℃反应5h后过滤,滤液经旋转蒸发除去溶剂,用乙醚沉淀洗涤,离心、干燥后得到红色固体产物M2,产率为88%;(2) React 0.196g M1 (0.5mmol) with 0.51g p-toluenesulfonic acid (2.7mmol) in 2mL deionized aqueous solution at 55°C for 5h, then filter, remove the solvent by rotary evaporation, wash with ether precipitation, centrifuge, After drying, red solid product M2 was obtained with a yield of 88%;
M1(0.196g,0.5mmol)与1.25mL对甲基苯磺酸甲酯(2.7mmol)于53℃反应19h,等温度降到室温后,过滤,通过旋转蒸发对滤液进行浓缩,然后用乙醚进行沉淀洗涤,离心、干燥后得到红色固体产物M3,产率为86%。M1 (0.196g, 0.5mmol) was reacted with 1.25mL methyl p-toluenesulfonate (2.7mmol) at 53°C for 19h, and after the temperature dropped to room temperature, filtered, the filtrate was concentrated by rotary evaporation, and then carried out with diethyl ether. The precipitate was washed, centrifuged and dried to obtain the red solid product M3 with a yield of 86%.
M2和M3为含1个胺基功能化的水溶性线性苝酰亚胺类化合物。M2 and M3 are water-soluble linear perylene imide compounds containing one amine group functionalization.
M2结构式为The structural formula of M2 is
M3结构式为The structural formula of M3 is
实施实例4:Implementation example 4:
1)将0.644g苝单酐(2.0mmol)和15mL三(2-氨基乙基)胺(100.5mmol)加入回流反应瓶中,溶液在氮气气氛下加热到105℃反应25小时,然后升温到172℃继续反应3小时,等温度降到室温后,加入体积比为1:3的乙醇与乙醚的混合溶剂,过滤,然后用甲苯、乙醚洗涤固体产物,干燥后得到红色固体产物M4,产率为86%。1) Add 0.644g perylene monoanhydride (2.0mmol) and 15mL tris(2-aminoethyl)amine (100.5mmol) into the reflux reaction flask, heat the solution to 105°C for 25 hours under a nitrogen atmosphere, and then raise the temperature to 172 Continue to react at ℃ for 3 hours, wait for the temperature to drop to room temperature, add a mixed solvent of ethanol and ether with a volume ratio of 1:3, filter, then wash the solid product with toluene and ether, and obtain the red solid product M4 after drying. The yield is 86%.
2)将150mgM4加入到0.72mL85wt%的甲酸溶液和0.53mL30wt%的甲醛溶液组成的混合溶液中,先在氮气气氛下于室温搅拌反应45分钟,然后加热到110℃反应15小时,等温度降到室温后,用乙醚沉淀洗涤3次,干燥后得到红色固体产物M5,产率为93%;2) Add 150mg M4 to the mixed solution consisting of 0.72mL85wt% formic acid solution and 0.53mL30wt% formaldehyde solution, stir and react at room temperature under nitrogen atmosphere for 45 minutes, then heat to 110°C for 15 hours, wait for the temperature to drop to After room temperature, it was precipitated and washed 3 times with ether, and after drying, the red solid product M5 was obtained with a yield of 93%;
3)将上述100mgM5溶于3mL甲醇溶剂中,然后滴加0.25mL的碘甲烷,在氮气气氛下加热到64℃,得到季铵盐苝单酰亚胺类衍生物M6。3) The above 100mg M5 was dissolved in 3mL methanol solvent, then 0.25mL iodomethane was added dropwise, and heated to 64°C under a nitrogen atmosphere to obtain the quaternary ammonium salt perylene monoimide derivative M6.
M5和M6为含3个胺基功能化的水溶性支化苝酰亚胺类化合物。M5 and M6 are water-soluble branched peryleneimide compounds containing three amine groups.
M5结构式为The structural formula of M5 is
M6结构式为The structural formula of M6 is
将实施例1和2制备的水溶性苝酰亚胺类化合物P2,P3,P5和P6作为DNA嵌插剂进行研究。The water-soluble peryleneimide compounds P2, P3, P5 and P6 prepared in Examples 1 and 2 were used as DNA intercalators for research.
1)紫外吸收光谱测试:将实施例1和2制备的水溶性苝酰亚胺类化合物P2,P3,P5和P6分别用磷酸缓冲液(10mM,pH7.4)配制为浓度为5μM的溶液,按照摩尔比为1:0,1:1,5:2,1:3加入Ct-DNA,于室温放置12h后,对样品进行紫外吸收光谱测试。实验结果显示P2,P3,P5和P6样品中加入Ct-DNA后,紫外吸收光谱强度减弱,且其最大峰位置伴随有红移现象。1) Ultraviolet absorption spectrum test: the water-soluble peryleneimide compounds P2, P3, P5 and P6 prepared in Examples 1 and 2 were respectively prepared into solutions with a concentration of 5 μM in phosphate buffer (10 mM, pH 7.4), Ct-DNA was added according to the molar ratio of 1:0, 1:1, 5:2, and 1:3, and after 12 hours at room temperature, the samples were tested by ultraviolet absorption spectrum. The experimental results showed that after adding Ct-DNA to P2, P3, P5 and P6 samples, the intensity of ultraviolet absorption spectrum was weakened, and the maximum peak position was accompanied by red shift.
2)荧光发射光谱测试:将上述步骤1)配制的水溶性苝酰亚胺类化合物样品溶液进行荧光发射光谱测试。实验结果显示,P2,P3,P5和P6样品中加入Ct-DNA后,荧光发射光谱强度减弱。2) Fluorescence emission spectrum test: The water-soluble peryleneimide compound sample solution prepared in the above step 1) was subjected to a fluorescence emission spectrum test. The experimental results showed that after adding Ct-DNA to P2, P3, P5 and P6 samples, the intensity of fluorescence emission spectrum was weakened.
3)CD光谱测试:固定Ct-DNA浓度为80μM,在磷酸缓冲液(10mM,pH7.4)中分别添加P2,P3,P5和P6以及空白样品,配制为浓度为3μM的溶液,于室温放置1h后,对样品进行CD光谱测试。实验结果显示,Ct-DNA溶液中加入P2,P3,P5和P6后,277nm处的正信号CD峰强度增强,247nm处的负信号CD峰强度减弱。3) CD spectrum test: fix the concentration of Ct-DNA at 80 μM, add P2, P3, P5 and P6 and blank samples respectively in phosphate buffer (10 mM, pH7.4), prepare a solution with a concentration of 3 μM, and place it at room temperature After 1 h, the CD spectrum test was carried out on the sample. The experimental results showed that after adding P2, P3, P5 and P6 to the Ct-DNA solution, the CD peak intensity of the positive signal at 277nm was enhanced, and the CD peak intensity of the negative signal at 247nm was weakened.
紫外吸收、荧光发射光谱和CD光谱实验结果显示该水溶性苝酰亚胺类化合物P2,P3,P5和P6能够作为DNA嵌插剂插入到DNA碱基对间。The experimental results of ultraviolet absorption, fluorescence emission spectrum and CD spectrum show that the water-soluble peryleneimide compounds P2, P3, P5 and P6 can be inserted between DNA base pairs as DNA intercalators.
将实施例1和2制备的水溶性苝酰亚胺类化合物P2,P3,P5和P6作为细胞核染料的研究。The water-soluble peryleneimide compounds P2, P3, P5 and P6 prepared in Examples 1 and 2 were used as nuclear dyes.
将P2,P3,P5和P6(10μM)染色处理果蝇固定组织,一起培养1小时后,P2,P3,P5和P6能够与细胞核里的DNA相互作用,从而特异性的富集于细胞核,并且与商业化染料DAPI标记完全一致。Drosophila fixed tissues were stained with P2, P3, P5 and P6 (10 μM), and after 1 hour of incubation, P2, P3, P5 and P6 were able to interact with DNA in the nucleus, thereby specifically enriching in the nucleus, and It is completely consistent with the commercial dye DAPI labeling.
将实施例1和2制备的水溶性苝酰亚胺类化合物P2,P3,P5和P6作为抑制癌细胞生长药物的研究。The water-soluble peryleneimide compounds P2, P3, P5 and P6 prepared in Examples 1 and 2 were used as drugs for inhibiting the growth of cancer cells.
用四氮唑盐(microculturetetrozolium,MTT)还原法研究P2,P3,P5和P6对U2OS(人骨肉瘤)、HCT116(结肠癌)、Hela(子宫颈癌)和AGS(胃腺癌)癌细胞进行体外抑制癌细胞生长活性测试。实验结果如下表所示,显示P2和P3对U2OS、HCT116、Hela和AGS等癌细胞生长具有良好的抑制性。Inhibition of P2, P3, P5 and P6 on U2OS (human osteosarcoma), HCT116 (colon cancer), Hela (cervical cancer) and AGS (gastric adenocarcinoma) cancer cells in vitro using tetrazolium salt (microculturetetrozolium, MTT) reduction method Cancer cell growth activity test. The experimental results are shown in the table below, showing that P2 and P3 have good inhibitory effects on the growth of cancer cells such as U2OS, HCT116, Hela and AGS.
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310349220.0A CN103497154A (en) | 2013-08-12 | 2013-08-12 | Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells |
CN201410137897.2A CN103936731B (en) | 2013-08-12 | 2014-04-08 | A kind of water-soluble perylene diimide compounds and as the application of DNA intercalation agent in inhibiting tumor cell and tumour |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310349220.0A CN103497154A (en) | 2013-08-12 | 2013-08-12 | Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103497154A true CN103497154A (en) | 2014-01-08 |
Family
ID=49862442
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310349220.0A Pending CN103497154A (en) | 2013-08-12 | 2013-08-12 | Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells |
CN201410137897.2A Active CN103936731B (en) | 2013-08-12 | 2014-04-08 | A kind of water-soluble perylene diimide compounds and as the application of DNA intercalation agent in inhibiting tumor cell and tumour |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410137897.2A Active CN103936731B (en) | 2013-08-12 | 2014-04-08 | A kind of water-soluble perylene diimide compounds and as the application of DNA intercalation agent in inhibiting tumor cell and tumour |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN103497154A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103992788A (en) * | 2014-05-13 | 2014-08-20 | 中国科学院长春应用化学研究所 | Coronene derivative probe and preparation method thereof, and protein detection method based on coronene derivative probe and aptamer |
CN109517186A (en) * | 2018-11-15 | 2019-03-26 | 北京化工大学 | A kind of three-dimensional metalloid organic framework material that can stablize radical anion and its application method for photothermal conversion |
CN110143975A (en) * | 2019-05-20 | 2019-08-20 | 上海大学 | Fluorescence-labeled O6-benzylguanine derivatives of naphthalimide or peryleneimide and preparation method thereof |
CN110237076A (en) * | 2019-07-29 | 2019-09-17 | 河南大学 | Application of PDINCl in the preparation of antitumor drugs |
CN110846027A (en) * | 2019-09-23 | 2020-02-28 | 上海大学 | Fluorescent probe material for detecting acetylcholinesterase activity, preparation method and application thereof |
CN111892598A (en) * | 2019-05-05 | 2020-11-06 | 天津大学 | Imidazole-based magnetic ionic liquid containing peryleneimide structure, preparation method and application thereof |
CN112521388A (en) * | 2020-12-30 | 2021-03-19 | 河南大学 | Perylene bisimide derivative and application thereof |
CN115181065A (en) * | 2022-08-08 | 2022-10-14 | 河南大学 | A kind of perylene imide derivative and application |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105820272B (en) * | 2016-05-06 | 2018-01-23 | 河北大学 | Imide ring dextrin carbohydrate photodynamics compound and its preparation method and application |
CN107952482B (en) * | 2017-12-04 | 2020-06-16 | 清华大学 | A kind of preparation method and application of peryleneimide supramolecular nanofiber photocatalyst |
CN113121533B (en) * | 2021-03-24 | 2022-05-03 | 浙江工业大学 | Method for enhancing solubility of perylene diimide derivative |
CN114380826B (en) * | 2022-01-21 | 2024-02-23 | 吉林大学 | Perylene porous organic salt material with stable light and heat properties, and preparation method and application thereof |
CN114874211B (en) * | 2022-03-30 | 2023-09-26 | 西安交通大学 | A class of imide derivatives, preparation methods and applications in flow batteries |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2494799A (en) * | 1998-02-04 | 1999-08-23 | Board Of Regents, The University Of Texas System | Inhibition of human telomerase by a g-quadruplex-interaction compound |
CN103554106B (en) * | 2013-11-14 | 2016-05-25 | 中国科学院化学研究所 | Amido/amine oxide is modified perylene diimides derivative, its preparation method and application |
-
2013
- 2013-08-12 CN CN201310349220.0A patent/CN103497154A/en active Pending
-
2014
- 2014-04-08 CN CN201410137897.2A patent/CN103936731B/en active Active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103992788A (en) * | 2014-05-13 | 2014-08-20 | 中国科学院长春应用化学研究所 | Coronene derivative probe and preparation method thereof, and protein detection method based on coronene derivative probe and aptamer |
CN103992788B (en) * | 2014-05-13 | 2016-06-22 | 中国科学院长春应用化学研究所 | Coronene derivant probe, preparation method and the protein detection method based on coronene derivant probe Yu aptamer |
CN109517186A (en) * | 2018-11-15 | 2019-03-26 | 北京化工大学 | A kind of three-dimensional metalloid organic framework material that can stablize radical anion and its application method for photothermal conversion |
CN111892598B (en) * | 2019-05-05 | 2022-03-01 | 天津大学 | Imidazole magnetic ionic liquid containing perylene bisimide structure and preparation method and application thereof |
CN111892598A (en) * | 2019-05-05 | 2020-11-06 | 天津大学 | Imidazole-based magnetic ionic liquid containing peryleneimide structure, preparation method and application thereof |
CN110143975A (en) * | 2019-05-20 | 2019-08-20 | 上海大学 | Fluorescence-labeled O6-benzylguanine derivatives of naphthalimide or peryleneimide and preparation method thereof |
CN110143975B (en) * | 2019-05-20 | 2022-06-10 | 上海大学 | Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof |
CN110237076A (en) * | 2019-07-29 | 2019-09-17 | 河南大学 | Application of PDINCl in the preparation of antitumor drugs |
CN110846027A (en) * | 2019-09-23 | 2020-02-28 | 上海大学 | Fluorescent probe material for detecting acetylcholinesterase activity, preparation method and application thereof |
CN112521388A (en) * | 2020-12-30 | 2021-03-19 | 河南大学 | Perylene bisimide derivative and application thereof |
CN112521388B (en) * | 2020-12-30 | 2021-11-09 | 河南大学 | Perylene bisimide derivative and application thereof |
WO2022143183A1 (en) * | 2020-12-30 | 2022-07-07 | 河南大学 | Perylene diimide derivative pdic-nc, preparation method therefor and application thereof |
CN115181065A (en) * | 2022-08-08 | 2022-10-14 | 河南大学 | A kind of perylene imide derivative and application |
CN115181065B (en) * | 2022-08-08 | 2023-07-21 | 河南大学 | Perylene bisimide derivative and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103936731B (en) | 2016-04-27 |
CN103936731A (en) | 2014-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103936731B (en) | A kind of water-soluble perylene diimide compounds and as the application of DNA intercalation agent in inhibiting tumor cell and tumour | |
CN101418215B (en) | High molecule fluorescent detecting probe containing rhodamine gene and synthetic method | |
CN103409135B (en) | Rhodamine fluorescent molecular probe using quinoline derivative as identification group and synthesis method thereof | |
CN107501313A (en) | A kind of near infrared light hot dye and preparation and application based on azepine fluorine borine | |
CN108102408B (en) | Preparation and application of a near-infrared dye based on azafluoroborane | |
CN112079684A (en) | Pillar aromatic hydrocarbons and pillar aromatic hydrocarbon compounds with aggregation-induced luminescence effect, and preparation method and application thereof | |
CN112920095B (en) | Novel aggregation-induced emission endoplasmic reticulum fluorescent probe and preparation method and application thereof | |
KR102253839B1 (en) | Labeling dye and kit comprising the same | |
CN103666452A (en) | Methylbenzofuran quinoline type biological probe, and preparation method and application thereof | |
CN101638389B (en) | Polyamine derivative containing naphthalimide structure, preparation method and application thereof | |
CN104650610A (en) | Asymmetric near-infrared BODIPY fluorescent dye as well as preparation method and application thereof | |
CN106831719A (en) | A kind of many pyridine naphthalimide fluorescence dendrimers and its preparation method and application | |
CN107586292A (en) | Compound, its preparation method, fluorescent dye and fluorescence probe | |
CN114702447B (en) | Naphthalimide derivative and preparation method and application thereof | |
CN106632262B (en) | Triaryl pyridine derivate and the preparation method and application thereof of the one kind containing carbazole skelton | |
CN114181238B (en) | 7-ethyl-10-hydroxycamptothecine prodrug with fluorescence activity and preparation method and application thereof | |
CN114133413B (en) | Benzothiazole-triphenylamine compound and preparation method and application thereof | |
CN113354956B (en) | Near-infrared squaric acid dye connected with oxygen ether chain as well as preparation and application thereof | |
CN113527364B (en) | Mn (II) complex multi-photon absorption material and preparation method and application thereof | |
CN113308131B (en) | Carboxyl modified near-infrared squaric acid dye and preparation method and application thereof | |
CN111592560B (en) | Photosensitizer probe and preparation method and application thereof | |
CN110776498B (en) | Macrocyclic polyamine compound based on DEDPP-2TPA and its preparation method and use | |
CN110183640B (en) | Degradable polymer based on valerolactone derivative ring-opening polymerization, preparation method and application thereof | |
CN105968003A (en) | Citrate fluorescent compound and application thereof to mercury ion detection | |
CN113354612A (en) | Peruvian red-based RNA near-infrared fluorescent probe for mitochondria and nucleolus, preparation and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140108 |